Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.112950 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Andrew D J Pearson und 40 weiteren Autor:innen. Beteiligte Einrichtung: ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium. Electronic address: andy1pearson@btinternet.com. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neuroblastoma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium. Electronic address: andy1pearson@btinternet.com.
- St Jude Children's Research Hospital, Memphis, TN, USA.
- Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
- Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Amsterdam, the Netherlands.
- Zoe4Life, Sullens, Switzerland.
Zitieren
APA
Pearson, A. D. J., Federico, S., Gatz, S. A., Ortiz, M., Lesa, G., Scobie, N., Gounaris, I., Weiner, S. L., Weigel, B., Unger, T. J., Stewart, E., Smith, M., Slotkin, E. K., Reaman, G., Pappo, A., Nysom, K., Norga, K., McDonough, J., Marshall, L. V., …, & Vassal, G. (2023). Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.112950
Vancouver
Pearson ADJ, Federico S, Gatz SA, Ortiz M, Lesa G, Scobie N, et al. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.112950
BibTeX
@article{Pearson2023,
author = {Pearson, Andrew D J and Federico, Sara and Gatz, Susanne A and Ortiz, Michael and Lesa, Giovanni and Scobie, Nicole and Gounaris, Ioannis and Weiner, Susan L and Weigel, Brenda and Unger, T J and Stewart, Elizabeth and Smith, Malcolm and Slotkin, Emily K and Reaman, Gregory and Pappo, Alberto and Nysom, Karsten and Norga, Koen and McDonough, Joe and Marshall, Lynley V and Ludwinski, Donna and Ligas, Franca and Karres, Dominik and Kool, Marcel and Horner, Thierry J and Henssen, Anton and Heenen, Delphine and Hawkins, Douglas S and Gore, Lia and Bender, Julia Glade and Galluzzo, Sara and Fox, Elizabeth and de Rojas, Teresa and Davies, Barry R and Chakrabarti, Jayeta and Carmichael, Juliet and Bradford, Diana and Blanc, Patricia and Bernardi, Ronald and Benchetrit, Sylvie and Akindele, Korede and Vassal, Gilles},
title = {Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.112950}
}
EUVIMED